WaferGen Biosystems has appointed Rolland Carlson as president and CEO. Carlson assumes this role from Ivan Trifunovich, who has served as president and CEO since March 2012. Trifunovich has been appointed executive chairman of WaferGen.
Carlson most recently served as president and CEO of Asuragen. Prior to that post, he served in increasingly senior positions at Abbott Laboratories over a 20-year period, including as global general manager and vice president of molecular diagnostics for Vysis, an Abbott subsidiary.